Profile data is unavailable for this security.
About the company
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
- Revenue in USD (TTM)709.16m
- Net income in USD-113.47m
- Incorporated1998
- Employees2.20k
- LocationNeogenomics Inc9490 Neogenomics WayFORT MYERS 33912United StatesUSA
- Phone+1 (239) 768-0600
- Fax+1 (775) 329-0852
- Websitehttps://neogenomics.com/
More ▼
Mergers & acquisitions
| Acquired company | NEO:NAQ since announced | Transaction value |
|---|---|---|
| Pathline LLC | 10.59% | -- |
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrana Health Inc | 2.90bn | 9.54m | 954.46m | 1.90k | 100.33 | 1.21 | 20.22 | 0.3295 | 0.1897 | 0.1897 | 59.23 | 15.70 | 1.64 | -- | 9.82 | 1,524,450.00 | 0.5528 | 6.98 | 0.6496 | 8.46 | 10.25 | 16.79 | 0.3362 | 5.34 | -- | 2.78 | 0.6543 | 9.34 | 46.72 | 29.41 | -28.93 | 25.04 | 50.46 | -- |
| OPKO Health Inc | 642.07m | -180.40m | 959.63m | 3.00k | -- | 0.736 | -- | 1.49 | -0.2406 | -0.2406 | 0.8806 | 1.70 | 0.302 | 6.68 | 6.38 | 214,236.20 | -8.48 | -5.03 | -9.32 | -5.70 | 35.29 | 33.63 | -28.09 | -9.82 | 3.32 | -2.22 | 0.211 | -- | -17.41 | -4.59 | 71.82 | -- | 14.44 | -- |
| Clover Health Investments Corp | 1.77bn | -57.71m | 1.06bn | 570.00 | -- | 3.05 | -- | 0.5972 | -0.1143 | -0.1156 | 3.52 | 0.6726 | 2.93 | -- | 32.18 | 3,111,516.00 | -9.52 | -31.80 | -15.61 | -48.76 | -- | -- | -3.25 | -21.26 | -- | -- | 0.00 | -- | 8.77 | -- | 77.98 | -- | -- | -- |
| Pennant Group Inc | 847.27m | 26.70m | 1.09bn | 7.00k | 41.80 | 3.39 | 28.83 | 1.29 | 0.7563 | 0.7563 | 24.00 | 9.31 | 1.21 | -- | 9.41 | 121,039.10 | 4.27 | 2.38 | 5.15 | 2.81 | 20.13 | 21.05 | 3.53 | 2.48 | -- | 11.26 | 0.0705 | 0.00 | 27.59 | 15.48 | 68.61 | 54.70 | 24.78 | -- |
| InnovAge Holding Corp | 915.37m | 6.47m | 1.11bn | 2.44k | 175.76 | 4.32 | 50.24 | 1.21 | 0.0465 | 0.0465 | 6.74 | 1.89 | 1.74 | -- | 25.76 | 375,152.50 | 0.6333 | -5.80 | 0.9505 | -7.87 | 20.34 | 19.12 | 0.364 | -4.25 | -- | 6.50 | 0.1927 | -- | 11.76 | 8.52 | -42.06 | -- | -11.96 | -- |
| Lumexa Imaging Holdings Inc | 1.00bn | -43.47m | 1.30bn | 4.06k | -- | 7.80 | -- | 1.30 | -0.4597 | -0.4597 | 10.61 | 1.77 | -- | -- | -- | 246,893.50 | -- | -- | -- | -- | 13.66 | -- | -4.33 | -- | -- | 0.5332 | 0.8806 | -- | 1.38 | -- | 23.01 | -- | -- | -- |
| Ardent Health Inc | 6.33bn | 205.06m | 1.34bn | 19.20k | 6.43 | 1.08 | 2.98 | 0.2117 | 1.45 | 1.45 | 44.83 | 8.65 | 1.27 | 23.15 | 8.82 | 329,455.70 | 5.96 | -- | 8.08 | -- | 57.94 | -- | 4.69 | -- | 1.95 | 7.42 | 0.404 | -- | 10.29 | -- | 290.22 | -- | -- | -- |
| US Physical Therapy Inc | 758.71m | 36.02m | 1.34bn | 4.03k | 37.08 | 2.66 | 15.81 | 1.77 | 2.38 | 2.38 | 50.06 | 33.12 | 0.6819 | -- | 9.01 | 188,079.10 | 5.51 | 5.82 | 8.03 | 8.54 | 18.80 | 21.02 | 8.08 | 8.61 | -- | 12.98 | 0.17 | 68.72 | 11.00 | 6.85 | 52.86 | -2.37 | -2.05 | 9.07 |
| Acadia Healthcare Company Inc | 3.27bn | 107.36m | 1.43bn | 19.19k | 13.17 | 0.4501 | 4.75 | 0.4388 | 1.18 | 1.18 | 35.79 | 34.50 | 0.5317 | -- | 8.02 | 170,151.50 | 1.94 | 3.14 | 2.19 | 3.65 | -- | -- | 3.64 | 6.72 | 1.43 | 3.39 | 0.4125 | -- | 7.69 | 9.45 | 1,279.73 | 37.45 | 24.30 | -- |
| NeoGenomics, Inc. | 709.16m | -113.47m | 1.48bn | 2.20k | -- | 1.76 | -- | 2.09 | -0.8877 | -0.8877 | 5.55 | 6.50 | 0.4703 | 15.15 | 4.62 | 322,346.40 | -7.52 | -4.23 | -8.66 | -4.55 | 43.46 | 40.72 | -16.00 | -11.71 | 3.62 | -- | 0.2894 | -- | 11.65 | 10.07 | 10.51 | -- | 15.44 | -- |
| Aveanna Healthcare Holdings Inc | 2.29bn | 75.46m | 1.67bn | 3.50k | 21.70 | 168.16 | 19.45 | 0.7278 | 0.3678 | 0.3678 | 11.01 | 0.0475 | 1.33 | -- | 7.69 | 654,454.60 | 4.37 | -10.76 | 5.72 | -13.00 | 33.57 | 31.32 | 3.29 | -11.05 | -- | 1.83 | 0.9933 | -- | 6.82 | 7.90 | 91.88 | -- | -17.60 | -- |
| Pediatrix Medical Group Inc | 1.92bn | 162.19m | 1.84bn | 2.15k | 11.28 | 2.07 | 9.95 | 0.9591 | 1.90 | 1.90 | 22.60 | 10.38 | 0.8991 | -- | 7.42 | 894,159.10 | 7.59 | 0.0108 | 9.24 | 0.0129 | -- | -- | 8.44 | 0.0155 | -- | 14.61 | 0.4035 | 0.00 | 0.9164 | 2.49 | -64.00 | -- | 2.71 | -- |
| Progyny Inc | 1.27bn | 56.57m | 1.86bn | 675.00 | 34.50 | 3.32 | 30.45 | 1.46 | 0.6246 | 0.6246 | 13.95 | 6.50 | 1.74 | -- | 4.76 | 1,879,539.00 | 7.77 | 11.31 | 10.92 | 15.54 | 22.94 | 21.65 | 4.46 | 6.66 | -- | -- | 0.00 | 0.00 | 7.22 | 38.42 | -12.41 | -- | 12.83 | -- |
| Surgery Partners Inc | 3.29bn | -171.40m | 1.94bn | 15.00k | -- | 1.12 | 11.20 | 0.590 | -1.36 | -1.36 | 25.94 | 13.41 | 0.4248 | 27.71 | 5.86 | 219,206.70 | 0.301 | 0.9726 | 0.4297 | 1.36 | 26.57 | 26.23 | 0.7086 | 2.46 | 1.72 | 2.29 | 0.5007 | -- | 13.52 | 11.20 | -1,312.61 | -- | 4.20 | -- |
| Select Medical Holdings Corp | 4.06bn | -34.63m | 2.01bn | 30.00k | -- | 1.19 | 12.28 | 0.4954 | -0.2592 | 0.9205 | 32.71 | 13.64 | 0.5927 | -- | 4.30 | 135,206.50 | 0.2021 | 3.00 | 0.2564 | 3.85 | 11.92 | 12.70 | 0.341 | 4.19 | -- | 2.25 | 0.4673 | 32.73 | 7.48 | -0.9982 | 10.99 | -15.13 | 7.17 | -- |
Data as of Feb 12 2026. Currency figures normalised to Neogenomics Inc's reporting currency: US Dollar USD
56.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 17.58m | 13.59% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 12.84m | 9.92% |
| First Light Asset Management LLCas of 30 Sep 2025 | 9.93m | 7.67% |
| Greenhouse Funds LLLPas of 30 Sep 2025 | 8.22m | 6.35% |
| Millennium Management LLCas of 02 Dec 2025 | 6.48m | 5.01% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 5.02m | 3.88% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 3.68m | 2.84% |
| Schroder Investment Management North America, Inc.as of 30 Sep 2025 | 3.48m | 2.69% |
| D. E. Shaw & Co. LPas of 30 Sep 2025 | 3.30m | 2.55% |
| Geode Capital Management LLCas of 30 Sep 2025 | 3.13m | 2.42% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
